Intravenous Mepolizumab In Children With Eosinophilic Esophagitis
NCT00358449
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Oesophagitis, Eosinophilic
Interventions
DRUG:
mepolizumab
Sponsor
GlaxoSmithKline